Search

Author/Creator Figg, W. Douglas

1. Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum‐resistant or ‐refractory epithelial ovarian cancer. Issue 4 (13th November 2015)

Authors:
Noonan, Anne M.; Bunch, Kristen P.; Chen, Jin‐Qiu; Herrmann, Michelle A.; Lee, Jung‐Min; Kohn, Elise C.; O'Sullivan, Ciara C.; Jordan, Elizabeth; Houston, Nicole; Takebe, Naoko; Kinders, Robert J.; Cao, Liang; Peer, Cody J.; Figg, W. Douglas; Annunziata, Christina M.
Journal:
Cancer
Issue:
Volume 122:Issue 4(2016)
Page Start:
588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Synthesis of a stable and orally bioavailable englerin analogue. Issue 11 (1st June 2016)

Authors:
Fash, David M.; Peer, Cody J.; Li, Zhenwu; Talisman, Ian J.; Hayavi, Sima; Sulzmaier, Florian J.; Ramos, Joe W.; Sourbier, Carole; Neckers, Leonard; Figg, W. Douglas; Beutler, John A.; Chain, William J.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 11(2016)
Page Start:
2641
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search